Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005

被引:56
|
作者
Barnett, Scott D. [1 ]
Ad, Niv [1 ]
机构
[1] Inova Heart & Vasc Inst, Falls Church, VA 22042 USA
来源
关键词
QUALITY-OF-LIFE; ASCENDING AORTA; REPLACEMENT; REPAIR; REIMBURSEMENT; ENDOCARDITIS; EXPERIENCE; SURVIVAL; PROLAPSE; DECADE;
D O I
10.1016/j.jtcvs.2008.08.071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The surgical treatment of valvular heart disease has changed significantly in the past decade with more mitral valves being repaired and tissue valves implanted in the aortic position. The National Inpatient Sample was used to document national trends of primary isolated aortic and mitral valve surgical procedures. Methods: Subjects were adult patients who had an isolated aortic or mitral valve repair or replacement in the United States. Estimated institution cost and total billed charges data were provided by the Centers for Medicare and Medicaid Services. Results: From 1998 to 2005, an estimated 330,000 aortic or mitral valve procedures were performed in the United States (repair, n - 46,342; replacement, n - 287,989). Since 1998, annual valve repair or replacement procedures increased 186.6% and 12.6%, respectively. Aortic valve repair or replacement procedures increased 102.5% and 28.0%, respectively, with an increased percentage for repairs from 2.0% in 1998 to 3.1% in 2005. Mitral valve repair procedures increased from 18.9% in 1998 to 45.8% in 2005, with mitral replacements decreasing 17.2% over the same period. Since 1998, the total hospital billed charges for aortic valve repair procedures increased 80.6% and aortic valve replacement procedures 90.4%; mitral valve repair procedures increased from 37.8%, replacement 42.0%. Annual increases in estimated institution cost increased for both aortic and mitral procedures on average 8% to 9%. Conclusion: During the last decade the practice of valve surgery has changed significantly. The surgical treatment for mitral disease has transitioned to primarily one of repair, not replacement, with the use of bioprostheses more than doubled. For the aortic position, the primary procedure remained valve replacement with bioprosthesis being the valve of choice. Regardless of valve disease, institutional costs and charges for the surgical treatment have greatly outpaced physician reimbursement.
引用
收藏
页码:1422 / 1429
页数:8
相关论文
共 50 条
  • [21] Is prophylactic aortic valve replacement indicated during mitral valve surgery for mild to moderate aortic valve disease?
    Ha, JW
    Choi, SH
    Chang, BC
    Nam, CM
    Jang, Y
    Chung, N
    Shim, WH
    Cho, SY
    Kim, SS
    ANNALS OF THORACIC SURGERY, 2002, 74 (04): : 1115 - 1119
  • [22] Mitraclip Followed by Surgical Aortic Valve Replacement: Hybrid Techniques for Regurgitant Aortic and Mitral Valve Disease
    Eudailey, Kyle
    Hamid, Nadira
    Hahn, Rebecca T.
    Kodali, Susheel
    Gray, William
    George, Isaac
    ANNALS OF THORACIC SURGERY, 2016, 102 (02): : E83 - E85
  • [23] Volume-Outcome Association of Mitral Valve Surgery in the United States
    Badhwar, Vinay
    Vemulapalli, Sreekanth
    Mack, Michael A.
    Gillinov, A. Marc
    Chikwe, Joanna
    Dearani, Joseph A.
    Grau-Sepulveda, Maria, V
    Habib, Robert
    Rankin, J. Scott
    Jacobs, Jeffrey P.
    McCarthy, Patrick M.
    Bloom, Jordan P.
    Kurlansky, Paul A.
    von Ballmoos, Moritz C. Wyler
    Thourani, Vinod H.
    Edgerton, James R.
    Vassileva, Christina M.
    Gammie, James S.
    Shahian, David M.
    JAMA CARDIOLOGY, 2020, 5 (10) : 1092 - 1101
  • [24] Quality of mitral valve surgery at the United States Department of Veterans Affairs
    Crestanello, Juan A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (01): : 80 - 81
  • [25] Inflammatory Bowel Disease in the United States from 1998 to 2005: Has Infliximab Affected Surgical Rates?
    Cannom, Rebecca R.
    Kaiser, Andreas M.
    Ault, Glenn T.
    Beart, Robert W., Jr.
    Etzioni, David A.
    AMERICAN SURGEON, 2009, 75 (10) : 976 - 980
  • [26] Impact of complications on outcomes following aortic and mitral valve replacements in the United States
    Allareddy, V.
    Ward, M. M.
    Ely, J. W.
    Allareddy, V.
    Levett, J.
    JOURNAL OF CARDIOVASCULAR SURGERY, 2007, 48 (03): : 349 - 357
  • [27] Correlation between transthoracic echocardiography and cardiac catheterization in the grading of aortic and mitral valve disease in clinical practice
    Zahn, R
    Scherle, T
    Seidl, K
    Bergmeier, C
    Lotter, R
    Nohl, H
    Zander, M
    Senges, J
    HERZ KREISLAUF, 1997, 29 (05): : 135 - 141
  • [28] MITRAL VALVE DISEASE IN THE UNITED STATES: RETROSPECTIVE ANALYSIS OF HOSPITALIZATIONS AND SURGICAL PROCEDURES USING THE NATIONAL INPATIENT SAMPLE
    Stuntz, M. E.
    CARDIOLOGY, 2016, 134 : 454 - 454
  • [29] Quantifying the incremental cost of complications associated with mitral valve surgery in the United States
    Iribarne, Alexander
    Burgener, John D.
    Hong, Kimberly
    Raman, Jai
    Akhter, Shahab
    Easterwood, Rachel
    Jeevanandam, Valluvan
    Russo, Mark J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 143 (04): : 864 - 872
  • [30] SURGICAL MANAGEMENT OF COMBINED MITRAL-STENOSIS AND AORTIC-VALVE DISEASE
    WATSON, DCT
    MATTHEWS, HR
    MEADE, JB
    THORAX, 1976, 31 (04) : 490 - 490